Screener
ADMA Biologics ADMA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | Three Months ended June 30, 2026 | Three Months ended June 30, 2025 | Six Months ended June 30, 2026 | Six Months ended June 30, 2025 |
|---|---|---|---|---|
| INCOME BEFORE INCOME TAXES | 50,237 | 40,097 | 107,365 | 73,546 |
| Provision for income taxes | 12,415 | 5,878 | 24,215 | 12,424 |
| NET INCOME | $$37,822 | $34,219 | $83,150 | 61,122 |
| BASIC EARNINGS PER COMMON SHARE | $$0.17 | $0.14 | $0.36 | 0.26 |
| DILUTED EARNINGS PER COMMON SHARE | $$0.16 | $0.14 | $0.35 | 0.25 |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||||
| Basic | 228,232,503 | 241,490,715 | 232,136,480 | 238,309,156 |
| Diluted | 230,337,048 | 248,608,460 | 235,240,375 | 245,750,155 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's shares (diluted)?
- ADMA Biologics (ADMA) reported shares (diluted) of 230.3M in Q2 2026.
- How has ADMA Biologics's shares (diluted) changed year-over-year?
- ADMA Biologics's shares (diluted) decreased by 7.3% year-over-year, from 248.6M to 230.3M.
- What is the long-term trend for ADMA Biologics's shares (diluted)?
- Over 4 years (2021 to 2025), ADMA Biologics's shares (diluted) has grown at a 17.5% compound annual growth rate (CAGR), from 516.4M to 982.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about ADMA Biologics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude